Grocery chain Albertsons, which offers pharmacies, is suing the Cigna-owned pharmacy benefit manager Express Scripts for at ...

Express Scripts, a U.S. pharmacy benefits manager, and Propeller Health, a Madison, Wis.-based startup, are joining forces to advance treatment for patients with chronic respiratory problems, ...

ST. LOUIS (CN) — Express Scripts filed a federal lawsuit against the Federal Trade Commission on Tuesday, claiming its report blaming the pharmacy benefit management industry for rising drug costs was ...

Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...

The Federal Trade Commission is targeting the three largest pharmacy benefit managers over rebate schemes that allegedly inflate insulin prices for some consumers. “This perverse system results in ...

Canada's Competition Bureau has opened an antitrust investigation into Cigna's Express Scripts unit, seeking to probe its business practices in the pharmacy sector. The bureau said in an announcement ...

FRANKFORT, Ky. (AP) — Kentucky's attorney general has sued Express Scripts, claiming the big pharmacy benefit manager was at the center of an opioid dispensing chain that fueled a deadly addiction ...

Express Scripts, the pharmacy benefits services business of The Cigna Group’s Evernorth, is making it easier for people to access a broader range of care services at independent pharmacies A new ...

(Reuters) - The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover ...

Express Scripts Holding Co. gave Chairman and CEO George Paz a 50 percent hike in total compensation for 2012, a year in which the nation’s largest pharmacy benefits manager polished off a $29 billion ...

NEW YORK (Reuters) -Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade Commission on Tuesday over the regulator's recent drug pricing report, calling the report's conclusion that the ...